Buy FOXO4-DRI Online
FOXO4-DRI is a specialized senolytic peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells. This has made it one of the most intriguing experimental compounds in the emerging field of cellular senescence research.
Product Information
FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 interaction. Research suggests this can selectively promote apoptosis of senescent cells while attempting to spare healthy cells.
Recent research has expanded interest in FOXO4-DRI into vascular aging, reproductive aging, and brain-aging models.
How Does It Work?
FOXO4-DRI disrupts the FOXO4-p53 interaction, helping release p53 from senescent-cell survival signaling and promoting apoptosis of targeted senescent cells.
Benefits
Targets Senescent Cells
FOXO4-DRI is specifically designed to target one of the mechanisms that allows senescent cells to resist programmed cell death.
Supports Cellular-Aging Research
By selectively removing senescent cells in experimental models, FOXO4-DRI has become a major tool for studying cellular aging and senescence biology.
Supports Vascular-Aging Research
A 2026 study reported improved aortic function and reduced vascular aging markers in aged mice treated with FOXO4-DRI.
Supports Healthy Aging Research
Recent animal research has linked FOXO4-DRI with improved spermatogenesis in aged mice and reduced senescence-associated signaling, expanding interest beyond basic cell biology.
Side Effects
Because FOXO4-DRI remains experimental, human safety data are unavailable. Potential concerns include unintended cell depletion, inflammatory changes, tissue effects, and immune reactions.
Dosage
Published FOXO4-DRI research primarily uses animal-model dosing, with protocols varying significantly by study. These doses should not be converted into human self-administration schedules.
Research References
Hu Z, et al. FOXO4-DRI regulates endothelial cell senescence via the P53 signaling pathway. Front Bioeng Biotechnol. 2026. PMID: 41625068.
PubMed — FOXO4-DRI vascular-aging study
Li Y, et al. FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells. Exp Gerontol. 2024;195:112522. PMID: 39025385.
PubMed — FOXO4-DRI aging study
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party providers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information provided is for educational and informational purposes only. Dosage figures may reflect published research protocols, historical clinical use, or reported community practices and should not be interpreted as personalized medical instructions. Research findings—particularly those from animal, cellular, or small early-stage studies—do not establish that a product is safe or effective for every individual or condition.
